CapeStart Debuts MadeAi™, its GenAI-enabled Platform for Life Sciences that Transforms Literature Review and other Applications
At the ISPOR Europe 2024 Conference today, CapeStart, Inc. debuted MadeAi™—a generative AI-based platform that dramatically streamlines the synthesis of clinical information—with its first solution, MadeAi-LR. Supporting literature review, MadeAi-LR unlocks efficiency...

